SPI Infoamtion

1 Table Of Contents
1.1 List of Tables
1.2 List of Figures

2 Executive Summary

3 Global Cardiac Resynchronization Therapy Market : Market Characterization
3.1 Overview
3.2 Cardiac Resynchronization Therapy, Revenue ($ m), Historic, 2001 - 2008
3.3 Cardiac Resynchronization Therapy, Revenue ($ m), Forecast, 2008 - 2015
3.4 Cardiac Resynchronization Therapy: Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Positive Clinical Trial Data to Bolster Growth
3.4.1.2 Increasing Prevalence of Congestive Heart Failure (CHF) to Drive the CRT Market
3.4.2 Market Restraints
3.4.2.1 High Device Cost a Growth Limiting Factor
3.4.2.2 Low Awareness and Slow Uptake of Technology in Developing Countries will hamper Growth
3.4.2.3 Availability of Alternative Pharmacological Therapies Resulting in Low Prescription Rates
3.4.2.4 Negative Market Impact Due to Device Recalls
3.5 Cardiac Resynchronization Therapy: Perception Analysis
3.6 Cardiac Resynchronization Therapy: Opportunities and Unmet Need
3.7 Key Takeaway

4 Global Cardiac Resynchronization Therapy Market : Competitive Assessment
4.1 Overview
4.2 Strategic Competitive Assessment
4.3 Cardiac Resynchronization Therapy Company Shares 2008
4.4 Product Profiles of the Major Marketed Products in the Cardiac Resynchronization Therapy Market
4.4.1 Concerto CRT-D
4.4.1.1 Overview
4.4.1.2 Efficacy
4.4.1.3 Safety Profile
4.4.1.4 Pricing
4.4.1.5 Clinical Study details
4.4.2 Promote Plus CRT-D
4.4.2.1 Overview
4.4.2.2 Efficacy
4.4.2.3 Safety
4.4.2.4 Pricing
4.4.3 Anthem CRT-P
4.4.3.1 Overview
4.4.3.2 Efficacy
4.4.3.3 Safety
4.4.3.4 Pricing
4.5 Key Takeaway

5 Global Cardiac Resynchronization Therapy Market: Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Cardiac Resynchronization Therapy - Pipeline by Clinical Phase of Development
5.4 Profiles of Promising Devices in Clinical Development
5.4.1 PARADYM sonR
5.4.1.1 Overview
5.4.1.2 Efficacy
5.4.1.3 Safety
5.4.1.4 Clinical Study Details
5.4.2 Paradym CRT PhD
5.4.2.1 Overview
5.4.2.2 Efficacy
5.4.2.3 Safety
5.4.2.4 Clinical Study Details
5.4.3 Promote Quadra CRT-D
5.4.3.1 Overview
5.4.3.2 Efficacy
5.4.3.3 Safety
5.4.3.4 Clinical Study Details
5.5 Cardiac Resynchronization Therapy Market: List of Pipeline Products
5.6 Key Takeaway

6 Global Cardiac Resynchronization Therapy Market : Implications for Future Market Competition
6.1 Strategic Competitor Assessment

7 Global Cardiac Resynchronization Therapy Market: Emerging Companies
7.1 Introduction
7.2 Boston Scientific
7.2.1 Overview
7.2.2 Cardiac Resynchronization Therapy Portfolio
7.2.2.1 Marketed Products
7.2.2.2 Pipeline Products
7.3 St. Jude Medical
7.3.1 Overview
7.3.2 Cardiac Resynchronization Therapy Portfolio
7.3.2.1 Marketed Products
7.3.2.2 Pipeline Products
7.4 Sorin Group
7.4.1 Overview
7.4.2 Cardiac Resynchronization Therapy Portfolio
7.4.2.1 Marketed Products
7.4.2.2 Pipeline Products
7.5 Odem Medical
7.5.1 Overview
7.5.2 Cardiac Resynchronization Therapy Portfolio
7.5.2.1 Marketed Products
7.5.2.2 Pipeline Products

8 Appendix
8.1 Definitions
8.1.1 Cardiac Resynchronisation Therapy
8.1.1.1 Cardiac Resynchronisation Therapy - Defibrillator
8.1.1.2 Cardiac Resynchronisation Therapy - Pacemaker
8.2 Research Methodology
8.3 Secondary Research
8.4 Primary Research
8.5 Models
8.6 Forecasts
8.7 Expert Panels
8.8 GlobalData Consulting
8.9 Contact Us
8.10 Disclaimer

List of Figures
Figure 1: Cardiac Resynchronization Therapy, Revenue ($ m), Global, 2001 - 2008
Figure 2: Cardiac Resynchronization Therapy, Revenue ($ m), Global, 2008 - 2015
Figure 3: Cardiac Resynchronization Therapy: Perception Analysis
Figure 4: Cardiac Resynchronization Therapy, Opportunity and Unmet Need
Figure 5: Strategic Competitive Assessment
Figure 6: Cardiac Resynchronization Therapy, Company Shares - 2008
Figure 7: Technology Trends Analytic Framework
Figure 8: Technology Trends Analytic Framework - Descriptions
Figure 9: Cardiac Resynchronization Therapy - Pipeline by Clinical Phase of Development
Figure 11: GlobalData Methodology

List of Tables
Table 1: Cardiac Resynchronization Therapy, Revenue ($ m), Global, 2001 - 2008
Table 2: Cardiac Resynchronization Therapy, Revenue ($ m), Global, 2008 - 2015
Table 3: Cardiac Resynchronization Therapy Clinical Trials and Key Findings - I
Table 4: Cardiac Resynchronization Therapy Clinical Trials and Key Findings - II
Table 5: Cardiac Resynchronization Therapy, Company Shares - 2008
Table 6: Cardiac Resynchronization Therapy Pipeline Product Summary
Table 7: Cardiac Resynchronization Therapy - Marketed Products
Table 8: Cardiac Resynchronization Therapy - Pipeline Product
Table 9: Cardiac Resynchronization Therapy - Marketed Product
Table 10: Cardiac Resynchronization Therapy - Pipeline Product
Table 11: Cardiac Resynchronization Therapy - Marketed Product
Table 12: Cardiac Resynchronization Therapy - Pipeline Product
Table 13: Cardiac Resynchronization Therapy - Pipeline Product